Title: FDA Grants Therapy Designation for Ocrelizumab in Primary Progressive MS
Description: FDA grants breakthrough therapy designation for the investigational medicine Ocrelizumab (OCREVUS) for treatment of primary progressive multiple sclerosis (PPMS)
URL: https://www.disabled-world.com/medical/clinical-trials/ocrelizumab.php